BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31439233)

  • 21. Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.
    Iyama Y; Nakaura T; Katahira K; Iyama A; Nagayama Y; Oda S; Utsunomiya D; Yamashita Y
    Eur Radiol; 2017 Sep; 27(9):3600-3608. PubMed ID: 28289941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.
    Gupta RT; Kauffman CR; Garcia-Reyes K; Palmeri ML; Madden JF; Polascik TJ; Rosenkrantz AB
    AJR Am J Roentgenol; 2015 Aug; 205(2):331-6. PubMed ID: 26204283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The performance of intravoxel-incoherent motion diffusion-weighted imaging derived hypoxia for the risk stratification of prostate cancer in peripheral zone.
    Chen Z; Xue Y; Zhang Z; Li W; Wen M; Zhao Y; Li J; Weng Z; Ye Q
    Eur J Radiol; 2020 Apr; 125():108865. PubMed ID: 32058895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance of multiparametric MRI parameters for Gleason score and cellularity metrics of prostate cancer in different zones: a quantitative comparison.
    Gao J; Zhang Q; Zhang C; Chen M; Li D; Fu Y; Lv X; Zhang B; Guo H
    Clin Radiol; 2019 Nov; 74(11):895.e17-895.e26. PubMed ID: 31337490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
    Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
    Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion kurtosis imaging does not improve differentiation performance of breast lesions in a short clinical protocol.
    Palm T; Wenkel E; Ohlmeyer S; Janka R; Uder M; Weiland E; Bickelhaupt S; Ladd ME; Zaitsev M; Hensel B; Laun FB
    Magn Reson Imaging; 2019 Nov; 63():205-216. PubMed ID: 31425816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate Cancer.
    Vos EK; Kobus T; Litjens GJ; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Maas MC; Scheenen TW
    Invest Radiol; 2015 Aug; 50(8):490-7. PubMed ID: 25867656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusion-weighted imaging of prostate cancer using a statistical model based on the gamma distribution.
    Shinmoto H; Oshio K; Tamura C; Soga S; Okamura T; Yamada K; Kaji T; Mulkern RV
    J Magn Reson Imaging; 2015 Jul; 42(1):56-62. PubMed ID: 25223894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravoxel Incoherent Motion (IVIM) Diffusion Weighted Imaging (DWI) in the Periferic Prostate Cancer Detection and Stratification.
    Pesapane F; Patella F; Fumarola EM; Panella S; Ierardi AM; Pompili GG; Franceschelli G; Angileri SA; Magenta Biasina A; Carrafiello G
    Med Oncol; 2017 Mar; 34(3):35. PubMed ID: 28144814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results.
    Kim CK; Park BK; Han JJ; Kang TW; Lee HM
    J Comput Assist Tomogr; 2007; 31(3):449-54. PubMed ID: 17538295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-tensor MRI at 3 T: differentiation of central gland prostate cancer from benign prostatic hyperplasia.
    Park SY; Kim CK; Park BK; Ha SY; Kwon GY; Kim B
    AJR Am J Roentgenol; 2014 Mar; 202(3):W254-62. PubMed ID: 24555622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of observation size and apparent diffusion coefficient (ADC) value in PI-RADS v2.1 assessment category 4 and 5 observations compared to adverse pathological outcomes.
    Abreu-Gomez J; Walker D; Alotaibi T; McInnes MDF; Flood TA; Schieda N
    Eur Radiol; 2020 Aug; 30(8):4251-4261. PubMed ID: 32211965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transition zone prostate cancer: Logistic regression and machine-learning models of quantitative ADC, shape and texture features are highly accurate for diagnosis.
    Wu M; Krishna S; Thornhill RE; Flood TA; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Sep; 50(3):940-950. PubMed ID: 30701625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores.
    Wibmer A; Hricak H; Gondo T; Matsumoto K; Veeraraghavan H; Fehr D; Zheng J; Goldman D; Moskowitz C; Fine SW; Reuter VE; Eastham J; Sala E; Vargas HA
    Eur Radiol; 2015 Oct; 25(10):2840-50. PubMed ID: 25991476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
    Hoeks CM; Hambrock T; Yakar D; Hulsbergen-van de Kaa CA; Feuth T; Witjes JA; Fütterer JJ; Barentsz JO
    Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate.
    Sato C; Naganawa S; Nakamura T; Kumada H; Miura S; Takizawa O; Ishigaki T
    J Magn Reson Imaging; 2005 Mar; 21(3):258-62. PubMed ID: 15723379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exponential apparent diffusion coefficient in evaluating prostate cancer at 3 T: preliminary experience.
    Park SY; Kim CK; Park JJ; Park BK
    Br J Radiol; 2016; 89(1058):20150470. PubMed ID: 26653866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of different mathematical models and different b-value ranges of diffusion-weighted imaging in peripheral zone prostate cancer detection using b-value up to 4500 s/mm2.
    Feng Z; Min X; Margolis DJ; Duan C; Chen Y; Sah VK; Chaudhary N; Li B; Ke Z; Zhang P; Wang L
    PLoS One; 2017; 12(2):e0172127. PubMed ID: 28199367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The histogram analysis of diffusion-weighted intravoxel incoherent motion (IVIM) imaging for differentiating the gleason grade of prostate cancer.
    Zhang YD; Wang Q; Wu CJ; Wang XN; Zhang J; Liu H; Liu XS; Shi HB
    Eur Radiol; 2015 Apr; 25(4):994-1004. PubMed ID: 25430007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.